MétaCan
Menu
Back to cohort
Record W4324132274 · doi:10.1016/s0960-9776(23)00123-6

P004 Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trial

2023· article· en· W4324132274 on OpenAlexaff
F. Cao, Z. Ma, G. Hu, X. Zhu, S. Li, Siteng Chen, B. Chen, Z. Li, W. Wu, X. Ji, J. Shu, Danping Tao, X. Hu, Meng Zheng, O. Wang, Qiaoli Feng, Jia-Yu Hao, Xuezhong Li

Bibliographic record

VenueThe Breast · 2023
Typearticle
Languageen
FieldMedicine
TopicHER2/EGFR in Cancer Research
Canadian institutionsSeagen (Canada)
Fundersnot available
KeywordsMedicineTrastuzumabOpen labelOncologyAdjuvantBreast cancerInternal medicineAdjuvant therapyClinical trialCancer

Abstract

fetched live from OpenAlex

Secondary objectives will include assessment of demographic and tumor characteristics, treatment compliance and switching, DFS, OS, safety parameters, additional QoL parameters, and hormone levels (estrone, estradiol, and follicle-stimulating hormone) as a measure of Ovarian Function Suppression (OFS).These parameters will allow researchers to investigate possible relationships between disease characteristics, treatment selection and clinical outcomes, with a focus on factors predicting treatment switching, suboptimal OFS and clinically significant changes in QoL.Results: The study is ongoing, with completion projected for July 2024.Interim analyses are planned for 2023 and 2024.Conclusion(s): This study will provide useful real-world information regarding QoL changes and clinical management of patients treated with OFS.The results generated will also provide insights into factors influencing treatment selection, with potential implications for treatment adherence and outcome optimization.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesInsufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.493
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.049
GPT teacher head0.392
Teacher spread0.344 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueThe BreastSame topicHER2/EGFR in Cancer ResearchFrench-language works237,207